Podcasts about Harvard Medical School

On this episode Gil sits with Michael Rosenblatt, MD, one of the most accomplished physician-scientists in modern medicine. He is former Chief Medical Officer of Merck, where he led global scientific strategy and medical affairs. Previously he served as Dean of Tufts University School of Medicine, Chief Scientific Officer at Vertex Pharmaceuticals, and Professor of Medicine at Harvard Medical School, where he advanced groundbreaking research in endocrinology, metabolic bone disease, and translational science. We discuss the intersection of academia, biotechnology, pharmaceutical innovation, and the clinical science shaping modern drug development and the future of precision therapeutics.

On this episode of the Sports Medicine Primer Series, host Dr. Zainab Shirazi, MD, is joined by Dr. Adam Tenforde, MD, to discuss how to manage a case of hip pain in a 25-year-old recreational weightlifter. The goal of this ongoing series is to provide an audio study aid for anyone pursuing a career as a sports medicine physician and to prepare them for a sports medicine fellowship. Dr. Tenforde is an assistant professor in the Department of Physical Medicine and Rehabilitation at Harvard Medical School. He is a sports medicine physician at the Spaulding National Running Center – one of the only centers in the United States exclusively dedicated to the diagnosis and treatment of running-related injuries. He has the unique perspective of being both a doctor and a former professional runner who was an All-American at Stanford University, where he contributed to three NCAA National Team Championships and later qualified for the Olympic trials. Dr. Shirazi is an Attending Physician at Women's Health, Sports & Performance (WHSP) Medical in Brighton, MA, and a dual board-certified physician in Sports Medicine and Physical Medicine & Rehabilitation. She has a passion for advancing the health and performance of female athletes and specializes in the non-operative management of musculoskeletal and sports-related injuries, providing comprehensive care for athletes of all ages and abilities.   Resources Mountjoy M, Ackerman KE, Bailey DM, et al. 2023 International Olympic Committee's (IOC) consensus statement on Relative Energy Deficiency in Sport (REDs). Br J Sports Med. 2023;57(17):1073-1097. doi:1136/bjsports-2023-106994 Kraus E, Tenforde AS, Nattiv A, et al. Bone stress injuries in male distance runners: higher modified Female Athlete Triad Cumulative Risk Assessment scores predict increased rates of injury. Br J Sports Med. 2019;53(4):237-242. doi:1136/bjsports-2018-099861 Hoenig T, Ackerman KE, Beck BR, et al. Bone stress injuries. Nat Rev Dis Primers. 2022;8(1):26. doi:1038/s41572-022-00352-y Nattiv A, Kennedy G, Barrack MT, et al. Correlation of MRI grading of bone stress injuries with clinical risk factors and return to play: a 5-year prospective study in collegiate track and field athletes. Am J Sports Med. 2013;41(8):1930-1941. doi:1177/0363546513490645 Hoenig T, Tenforde AS, Strahl A, Rolvien T, Hollander K. Does Magnetic Resonance Imaging Grading Correlate With Return to Sports After Bone Stress Injuries? A Systematic Review and Meta- analysis. Am J Sports Med. 2022;50(3):834-844. doi:1177/0363546521993807 Barrack MT, Fredericson M, Tenforde AS, Nattiv A. Evidence of a cumulative effect for risk factors predicting low bone mass among male adolescent athletes. Br J Sports Med. 2017;51(3):200-205. doi:1136/bjsports-2016-096698 Robertson GA, Wood AM. Femoral Neck Stress Fractures in Sport: A Current Concepts Review. Sports Med Int Open. 2017;1(2):E58-E68. doi:1055/s-0043-103946 Fredericson M, Roche M, Barrack MT, et al. Healthy Runner Project: a 7-year, multisite nutrition education intervention to reduce bone stress injury incidence in collegiate distance runners. BMJ Open Sport Exerc Med. 2023;9(2):e001545. doi:1136/bmjsem-2023-001545 Roche M, Nattiv A, Sainani K, et al. Higher Triad Risk Scores Are Associated With Increased Risk for Trabecular-Rich Bone Stress Injuries in Female Runners. Clin J Sport Med. 2023;33(6):631-637. doi:1097/JSM.0000000000001180 Burke LM, Ackerman KE, Heikura IA, Hackney AC, Stellingwerff T. Mapping the complexities of Relative Energy Deficiency in Sport (REDs): development of a physiological model by a subgroup of the International Olympic Committee (IOC) Consensus on REDs. Br J Sports Med. 2023;57(17):1098-1108. doi:1136/bjsports-2023-107335 Tenforde AS, Barrack MT, Nattiv A, Fredericson M. Parallels with the Female Athlete Triad in Male Athletes. Sports Med. 2016;46(2):171-182. doi:1007/s40279-015-0411-y Hoenig T, Eissele J, Strahl A, et al. Return to sport following low-risk and high-risk bone stress injuries: a systematic review and meta-analysis. Br J Sports Med. 2023;57(7):427-432. doi:1136/bjsports-2022-106328 Nattiv A. Stress fractures and bone health in track and field athletes. J Sci Med Sport. 2000;3(3):268-279. doi:1016/s1440-2440(00)80036-5 Nattiv A, Armsey TDJ. Stress injury to bone in the female athlete. Clin Sports Med. 1997;16(2):197-224. doi:1016/s0278-5919(05)70017-x Nattiv A, De Souza MJ, Koltun KJ, et al. The Male Athlete Triad-A Consensus Statement From the Female and Male Athlete Triad Coalition Part 1: Definition and Scientific Basis. Clin J Sport Med. 2021;31(4):335-348. doi:1097/JSM.0000000000000946 Fredericson M, Kussman A, Misra M, et al. The Male Athlete Triad-A Consensus Statement From the Female and Male Athlete Triad Coalition Part II: Diagnosis, Treatment, and Return-To-Play. Clin J Sport Med. 2021;31(4):349-366. doi:1097/JSM.0000000000000948

Results of a phase II trial of olaparib in combination with ceralasertib in patients with recurrent and unresectable osteosarcomaOsteosarcoma Webinar Series: Katie Janeway, MD and Suzanne Forrest, MD join us on OsteoBites to discuss results of a phase II trial of olaparib in combination with ceralasertib in patients with recurrent and unresectable osteosarcoma.Dr. Janeway received her MD and MMSc from Harvard Medical School. She completed her pediatrics residency and her Pediatric Hematology-Oncology fellowship at Boston Children's Hospital and Dana-Farber Cancer Institute. She is an Associate Professor of Pediatrics, a Senior Physician who cares for young people with sarcoma, and Director of Clinical Genomics. Dr. Janeway's research is focused on precision oncology and bone sarcomas. She leads clinical trials both as an independent investigator and as the Chair of the Children's Oncology Group (COG) Bone Tumor Committee. The Janeway Laboratory leads several studies, which have enrolled and sequenced more than 2,500 patients with childhood cancers. They are using this data to deepen the understanding of clinical and genomic factors explaining prognosis and treatment response, and resistance, with a focus on sarcomas. In collaboration with Count Me In, the group is innovating patient partnerships in sarcoma research.Dr. Forrest completed her medical school training at Yale University, followed by pediatrics training in the Boston Combined Residency Program. She then pursued a pediatric oncology fellowship at Dana-Farber Cancer Institute / Boston Children's Hospital. Currently, she serves as an Assistant Professor of Pediatrics at Harvard Medical School and an Attending Physician in the Department of Hematology/Oncology at Dana-Farber / Boston Children's Cancer and Blood Disorders Center. Her research focuses on developing novel clinical trials that utilize cancer genomics to guide treatment strategies for pediatric solid tumors.After a short presentation on this research, they will take questions from attendees. Share your questions in advance with us at Christina@MIBAgents.org.

The Rich Zeoli Show- Hour 3: 5:05pm- Daniel Turner—Founder and Executive Director of Power the Future—joins The Rich Zeoli Show to recap President Donald Trump's speech in Mount Pocono, Pennsylvania. Are the president's policies leading to lower energy prices? 5:30pm- Dr. Jared Cooney Horvath—Neuroscientist, Educator, & Best-Selling Author—joins The Rich Zeoli Show to discuss his latest essay for The Free Press, “We Gave Students Laptops and Took Away Their Brains.” Dr. Horvath responds to claims that “our children are less cognitively capable than we were at their age”—noting that “starting around the year 2000, something changed. For the first time in the history of standardized cognitive measurement, Generation Z is consistently scoring lower than their parents on many key measures of cognitive development—from literacy and numeracy to deep creativity and general IQ. And the early data from Generation Alpha (born after 2012) suggests the downturn isn't slowing—it's accelerating.” So, what's to blame? “The tools we are using.” He has conducted research and taught at Harvard University and Harvard Medical School. You can read the full article here: https://www.thefp.com/p/we-gave-students-laptops-and-took. And find Dr. Horvath's book, “The Digital Delusion: How Classroom Technology Harms Our Kids' Learning—And How To Help Them Thrive Again,” here: https://a.co/d/5jeoZwz. You can learn more here: lmeglobal.com.

The Rich Zeoli Show- Full Show (12/10/2025): 3:05pm- Have technological advances over the last decade negatively impacted the mental health of young Americans? In an essay for the Free Press, Jonathan Haidt argues that Gen Z has lost its ability to focus, think critically, and often replaces meaningful relationships with simulations. If smartphones and apps have been psychologically damaging—what will the rise of artificial intelligence do? 3:15pm- On Wednesday, President Donald Trump held a roundtable discussion from the White House with several business leaders where he announced the launch of the Trump Gold Card: "The company can keep [employees] here, and they have a path to citizenship. Obviously, they have to be perfect people in America—and having passed the vetting, after 5 years, they'll be available to become citizens." 3:50pm- Is anyone answering the phones at the studio? Probably not. Plus, President Trump takes questions from the press. 4:05pm- While speaking from the White House, President Trump confirmed that the United States has seized an oil tanker off the coast of Venezuela. While speaking with Politico on Tuesday, Trump said that dictator Nicolas Maduro's “days are numbered” and would not rule out a ground invasion. 4:40pm- President Trump told Politico that his goal for Venezuela is to make sure its people are finally “treated well.” 4:45pm- Speaker Mike Johnson said he is “absolutely delighted that Jasmine Crockett is running for Senate in Texas” and that “it's one of the greatest things to happen to the Republican Party.” 4:50pm- Artificial intelligence is being used for strategic “price surging”—Matt has worthless knowledge and he's excited to share it. Plus, did the limited-edition holiday Coca Cola live up to expectations? It wasn't quite as “smooth” and “creamy” as Coke had promised. 5:05pm- Daniel Turner—Founder and Executive Director of Power the Future—joins The Rich Zeoli Show to recap President Donald Trump's speech in Mount Pocono, Pennsylvania. Are the president's policies leading to lower energy prices? 5:30pm- Dr. Jared Cooney Horvath—Neuroscientist, Educator, & Best-Selling Author—joins The Rich Zeoli Show to discuss his latest essay for The Free Press, “We Gave Students Laptops and Took Away Their Brains.” Dr. Horvath responds to claims that “our children are less cognitively capable than we were at their age”—noting that “starting around the year 2000, something changed. For the first time in the history of standardized cognitive measurement, Generation Z is consistently scoring lower than their parents on many key measures of cognitive development—from literacy and numeracy to deep creativity and general IQ. And the early data from Generation Alpha (born after 2012) suggests the downturn isn't slowing—it's accelerating.” So, what's to blame? “The tools we are using.” He has conducted research and taught at Harvard University and Harvard Medical School. You can read the full article here: https://www.thefp.com/p/we-gave-students-laptops-and-took. And find Dr. Horvath's book, “The Digital Delusion: How Classroom Technology Harms Our Kids' Learning—And How To Help Them Thrive Again,” here: https://a.co/d/5jeoZwz. You can learn more here: lmeglobal.com. 6:05pm- On Tuesday, President Donald Trump held a rally in Mount Pocono, Pennsylvania where he addressed American affordability challenges and the economy. During his speech he mocked former President Joe Biden and Rep. Ilhan Omar and noted that since his inauguration “we've created nearly 60,000 new Pennsylvania jobs, including 4,000 Pennsylvania manufacturing jobs.” 6:30pm- Carrie Severino—President of the Judicial Crisis Network (JCN) & Co-Author of the book, “Justice on Trial: The Kavanaugh Confirmation and the Future of the Supreme Court”—joins The Rich Zeoli Show to discuss U.S. Supreme Court oral arguments in the National Republican Senatorial Committee v. Federal Election Committee, a case involving limits on coordi ...

From Discovery to Delivery: Charting Progress in Gynecologic Oncology, hosted by Ursula A. Matulonis, MD, brings expert insights into the most recent breakthroughs, evolving standards, and emerging therapies across gynecologic cancers. Dr Matulonis is chief of the Division of Gynecologic Oncology and the Brock-Wilcon Family Chair at the Dana-Farber Cancer Institute and a professor of medicine at Harvard Medical School, both in Boston, Massachusetts. In this episode, Dr Matulonis sat down with guest Panagiotis (Panos) A. Konstantinopoulos, MD, PhD, to discuss the different subtypes of endometrial cancer and treatment developments for this disease. Dr Konstantinopoulos is the director of Translational Research in the Division of Gynecologic Oncology, the director of the Mellen and Eisenson Family Center for BRCA and Related Genes, and the Velma Eisenson Chair for Clinical and Translational Research at Dana-Farber Cancer Institute; as well as a professor of medicine at Harvard Medical School. Drs Matulonis and Konstantinopoulos explained that patients with mismatch repair–deficient (dMMR) tumors substantially benefit from a decreased risk of progression or death when immunotherapy is added to standard therapy. They noted that immunotherapy appears important for the management of dMMR tumors, even those in earlier stages or in patients who have no measurable disease remaining after surgery. For MMR-proficient (pMMR) tumors, Drs Matulonis and Konstantinopoulos highlighted that PD-1 blockade combined with chemotherapy improves survival vs chemotherapy alone, but that this benefit is not as substantial as that seen in dMMR disease. Crucially, they reported that if a pMMR tumor has no measurable disease after surgery, adding immune checkpoint blockade does not appear beneficial. They stated that tailored treatment approaches are key for managing pMMR disease subtypes. They added that hormonal therapy may be used upfront for slow-growing, estrogen receptor–positive metastatic disease. They continued by saying that DNA damage and replication stress are critical targets, particularly in p53-mutated tumors, like uterine serous cancers. Furthermore, they stressed that although the antibody-drug conjugate fam-trastuzumab deruxtecan-nxki (Enhertu) is highly effective in HER2-positive tumors, treatment with this agent requires monitoring for toxicities, including interstitial lung disease and decreased ejection fraction.

In cancer research, the “seed and soil” hypothesis posits that the tumor is like a seed of misbehaving cells taking root in the body. Whether it grows—and where it grows—depends on the conditions, or soil. Since this hypothesis was proposed more than 100 years ago, most research and treatments have focused on the seed, or tumor. For nearly 50 years, Rakesh Jain has been studying the soil. But in a seed-focused field, his work was seen as wasteful and radical. Now, that very same research has led to seven FDA-approved treatments for diseases including lung and liver cancer, and earned him a National Medal of Science in 2016. Host Flora Lichtman talks with Jain about how his fringe idea led to lifesaving cancer treatments. Guest: Dr. Rakesh K. Jain studies the biology of tumors at Harvard Medical School and Massachusetts General Hospital as a professor of radiation oncology.Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

We talk with Peter Grinspoon, MD—an internationally renowned expert on medical cannabis, drug policy, and addiction—about the U.S. Congress recriminalizing most hemp-derived products. The measure is set to take effect one year from enactment — around November 12, 2026. Dr. Grinspoon is a primary care physician and cannabis specialist at Massachusetts General Hospital and an Instructor in Medicine at Harvard Medical School. A certified Health and Wellness Coach, he has provided medical cannabis care for patients for two decades. He is a board member of the advocacy group Doctors for Drug Policy Reform and an advisor to the Parabola Group, which advocates for social justice in the cannabis space. He spent two years as an associate director of the Massachusetts Physician Health Service, treating and monitoring hundreds of physicians with addiction. Dr. Grinspoon is the author of "Free Refills: A Doctor Confronts His Addiction," “Seeing Through the Smoke: A Cannabis Specialist Untangles the Truth About Marijuana,” and he has a new book coming out in May 2026—"Aging Well with Cannabis: Feel Better, Sleep Better, and Live Better with Marijuana and CBD." ◘ Related Links: Dr. Grinspoon's website, www.petergrinspoon.com ◘ Transcript: bit.ly/3JoA2mz ◘ This podcast features the song “Follow Your Dreams” (freemusicarchive.org/music/Scott_Ho…ur_Dreams_1918) by Scott Holmes, available under a Creative Commons Attribution-Noncommercial (01https://creativecommons.org/licenses/by-nc/4.0/) license. ◘ Disclaimer: The content and information shared in GW Integrative Medicine is for educational purposes only and should not be taken as medical advice. The views and opinions expressed in GW Integrative Medicine represent the opinions of the host(s) and their guest(s). For medical advice, diagnosis, and/or treatment, please consult a medical professional.

In this episode of the SHEA Podcast, host Dr. Jonathan Ryder moderates a lively pro/con debate on one of the most discussed biomarkers in infectious diseases: procalcitonin. Joining the conversation are two experts with distinct perspectives: Dr. Michael Mansour, Clinician Investigator and Associate Professor of Infectious Diseases at Massachusetts General Hospital and Harvard Medical School, and Dr. Sheetal Kandiah, Senior Physician and Assistant Clinical Professor of Medicine in the Division of Infectious Diseases at Emory University; Director of the Antibiotic Stewardship Program at Grady Hospital. Together, they explore where PCT may (or may not) add value in antimicrobial stewardship programs. Tune in for an insightful exchange that will help stewards, clinicians, and ID professionals better understand where PCT fits into today's rapidly evolving diagnostic landscape.

Dr. Martin Moore-Ede is a leading expert on circadian rhythms and the effects of light on human health. As a professor at Harvard Medical School (1975–1998), he led the team that identified the suprachiasmatic nucleus, the brain's master biological clock. He later founded CIRCADIAN®, a global consulting firm helping 24/7 organizations improve health, safety, and productivity, and went on to establish the Circadian Light Research Center and CIRCADIAN ZircLight to develop biologically optimized LED lighting based on decades of research. Author of over 180 scientific papers and 10 books, including The Clocks That Time Us and The Twenty-Four Hour Society, Dr. Moore-Ede's work has profoundly shaped how we understand the relationship between light, circadian biology, and human performance. Dr. Martin Moore-Ede - Director, Circadian Light Research Center thelightdoctor.com ‪Book: THE LIGHT DOCTOR: Using Light to Boost Health, Improve Sleep, and Live Longer Daniel Sentker (Host) Chiropraktor M.Sc., Heilpraktiker, Referent und Mitgründer von Lichtblock: Instagram: @daniel.sentker Lichtblock: https://lichtblock.shop Instagram: @lichtblock.shop The Podcast: Lichtblock Professionals We introduce you to experts who can give you exciting insights and tips from the field and thus create new ways of thinking for you. The focus is on the areas of light, sleep and lifestyle. We also cover topics such as exercise, nutrition and mindset. With our podcast we want to support you in finding the best compromise between the digital world and nature. Red light and blueblocker glasses can be of great help. But the focus is not on our own products, we mainly want to promote a positive and healthy lifestyle. If you have any questions, comments or ideas, feel free to drop us a line at podcast@lichtblock.shop or on Instagram @lichtblock.shop Get 10 % on your order at lichtblock.shop with “LB10” for high quality blueblockers. Follow us on Instagram @lichtblock.shop or visit us on our English website: en.lichtblock.shop Enjoy!

Dr. Adam Dorsay, psychologist and host of the SuperPsyched podcast, interviews Dr. Sharon Chang, a distinguished surgical oncologist educated at Harvard Medical School. Dr. Chang shares her journey in the demanding field of surgical oncology, including the rigorous schedules, challenges of being a female in a traditionally male-dominated field, and work-life balance. She discusses her routines for maintaining physical and mental health, the creation of psychological safety within surgical teams, and the importance of caring deeply for patients. Dr. Chang also shares her transition into coaching, focusing on mental fitness for healthcare professionals, and her efforts to combat burnout and advocate for lifestyle medicine. The episode provides a compelling and insightful look into the high-stakes world of a cancer surgeon and the valuable lessons learned along the way.00:00 Introduction to SuperPsyched00:35 Meet Dr. Sharon Chang: A Life-Saving Surgeon03:00 Challenges and Triumphs of a Female Surgeon04:50 Balancing Surgery and Motherhood06:43 Self-Care and Physical Fitness08:29 A Day in the Life of a Surgeon15:30 Handling Surgical Surprises20:56 The Importance of Teamwork and Psychological Safety26:29 Exploring Plastic Surgery and Patient Experiences27:33 Communicating with Patients and Families28:01 The Impact of Social Media on Medical Information29:59 Humor in Medicine: Dr. Glaucomflecken and Misinformation https://youtube.com/@dglaucomflecken?si=6K46jj4z2LeMBfMZ32:35 Delivering Good and Bad News to Patients36:29 The Importance of Caring in Medicine43:13 Transitioning to a Career in Coaching47:30 Sharon Chang's Triple Aim for Healthcare51:35 Final Thoughts and ReflectionsHelpful Links:Sharon B. Chang, MD, FACS LinkedIn

This week, Thomas is joined once again by the founder of Internal Family Systems, Dr. Richard Schwartz, for a deep exploration of how we can integrate collective trauma work into our daily lives, relationships, and communities.Combining wisdom from psychology and spiritual traditions, they discuss fresh insights on creating a holistic healing framework for modern times that expands our traditional understanding of therapy and healing by addressing deeply ingrained ancestral and collective wounds.They also explore the power of accessing the core Self to help us release individual and inherited burdens, and how this process of unburdening can accelerate our collective evolution and influence the greater health of humanity.✨ Watch the video version of this episode on YouTube:

I'm thrilled to share some incredible insights from our latest podcast episode featuring the brilliant Tom Healy, co-founder of People Ops 360 and a leading expert in people performance systems. Tom has worked with prestigious organizations like the US Navy, Harvard Medical School, and Fortune 500 companies, and he's here to share his wealth of knowledge with us.Here are some key takeaways from our conversation that you won't want to miss:

Dr. Kirsten Viola Harrison has spent her professional career as a Psychologist studying and treating trauma disorders and their sequelae. She has had the opportunity to conduct research on PTSD at UCLA Neuropsychiatric Institute, as well as study at Georgetown University, Pepperdine Graduate School of Education and Psychology, Barry University and Pacifica Graduate Institute.Kirsten's continuing education has included summers at Harvard Medical School and conferences and training in Europe, supplementing her Masters degree in Biomedical Sciences. By far the most instrumental and informative in shaping her philosophy has been her direct work with trauma survivors, including near-death experiencers and those struggling with complex DID and PTSD. The creativity, passion and will to survive the unthinkable that her clients have endured and struggled through on their healing journeys, have given her life's work meaning and purpose beyond any professional training program.It is in honor of these courageous souls that Kirsten proudly and steadfastly continues to offer her knowledge, experience and clinical skills, in the hope that the greater good can be best served.More:Website:https://soulwisesolutions.com/Facebook:https://www.facebook.com/soulwiseteam/X (Twitter):https://x.com/soulwiseteamInstagram:https://www.instagram.com/soulwiseteam/TikTok:https://www.tiktok.com/@soulwiseteamYouTube:https://www.youtube.com/@UCoXkhnJ3SGDMKdS31B0NY8w

Send us a textDr. Abba Zubair, MD, PhD is a Professor of Laboratory Medicine and Pathology at the Mayo Clinic in Jacksonville, Florida ( https://www.mayo.edu/research/faculty/zubair-abba-c-m-d-ph-d/bio-00092417 ), where he also has served as the medical director of Transfusion Medicine and Stem Cell Therapy. Dr. Zubair earned his medical degree from Ahmadu Bello University in Zaria, Nigeria, and went on to complete a Ph.D. in Cancer Immunobiology at the University of Sheffield in England. From there, he pursued advanced training in pathology and transfusion medicine in the U.S., completing a residency at the University of Pennsylvania and a clinical fellowship at Harvard Medical School. For more than two decades, Dr. Zubair led the Stem Cell Therapy Laboratory at Mayo Clinic Florida, pioneering the development of clinical-grade cell therapy products. His research has focused on mesenchymal stem/stromal cells (MSC), hematopoietic stem cells (HSC), immune cells, and extracellular vesicles — with the aim of translating basic research into therapies for degenerative disease, brain injury, transplant-related complications, and beyond.In perhaps one of the most extraordinary bridges between earthly medicine and outer space, Dr. Zubair has sent his lab's stem cells to the International Space Station — aiming to understand how microgravity affects cell behavior, bone loss, and regenerative potential. This research has profound implications not only for astronauts, but for patients on Earth suffering from osteoporosis, bone degeneration, and other conditions. Beyond his scientific and clinical roles, Dr. Zubair is a devoted educator and leader: in 2024 he was named Vice Dean of the Mayo Clinic Alix School of Medicine (Florida), shaping the next generation of physicians; previously he served as Associate Dean of the Mayo Clinic School of Health Sciences and as Dean of Education at a Mayo-Clinic affiliated hospital venture in Abu Dhabi. #AbbaZubair #MayoClinic #LaboratoryMedicine #Pathology #TransfusionMedicine #StemCellTherapy #MesenchymalStemCells #StromalCells #HematopoieticStemCells #ImmuneCells #ExtracellularVesicles #Exosomes #Secretome #RegenerativeMedicine #Immunotherapy #Bioreactors #ClinicalGradeManufacturing #CosmicRadiation #DeepSpaceExploration #Microgravity #InternationalSpaceStation #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #STEM #Innovation #Technology #Science #ResearchSupport the show

Forrest is joined by psychiatrist Dr. Blaise Aguirre to discuss Borderline Personality Disorder (BPD) and Dialectical Behavioral Therapy (DBT). They explore how extreme emotional sensitivity can lead to despair, self-hatred, suicidality, and an intense fear of abandonment, and how DBT can teach the skills needed to regulate those feelings. They discuss the nature of self-hatred, how to change the stories you've told about yourself, and how their insight and empathy can make people with BPD some of his favorite clients to work with. About our Guest: Dr. Blaise Aguirre is the medical director of 3East at McLean Hospital, a residential DBT program for adolescents and young adults, and is an assistant professor of psychiatry at Harvard Medical School. He's also the co-author of a number of books including DBT for Dummies, and the author of I Hate Myself: Overcome Self-Loathing and Realize Why You're Wrong About You. Key Topics:  0:00: Introduction 4:05: Common features of BPD 15:16: Skill-building versus narrative work in therapy 22:10: What DBT looks like in practice 27:02: DBT skills: mindfulness, dialectic thinking, and opposite action 33:43: How to shift self-hatred 49:22: Stigmatization of BPD 53:25: BPD versus CPTSD 58:52: Recap Support the Podcast: We're on Patreon! If you'd like to support the podcast, follow this link. Sponsors Listen to Turning Points: Navigating Mental Health wherever you get your podcasts. Follow the show so you never miss an episode.  Level up your bedding with Quince. Go to Quince.com/BEINGWELL for free shipping on your order and three hundred and sixty-five -day returns. If you are exploring whether you might be neurodivergent, check out Hyperfocus with Rae Jacobson.  Skylight is offering our listeners $20 off their 10 inch Skylight Frame by going to myskylight.com/BEINGWELL. Go to Zocdoc.com/BEING to find and instantly book a top-rated doctor today. Sign up for a one-dollar-per-month trial period at shopify.com/beingwell.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Enid Martinez, MD is a Senior Associate in Critical Care at Boston Children's Hospital, and an Assistant Professor of Anaesthesia at Harvard Medical School. She is the Director of the Pediatric Critical Care Nutrition Program in the Division of Critical Care Medicine and Principal Investigator for a clinical-translational research program on gastrointestinal function and nutrition in pediatric critical illness.Learning Objectives:By the end of this podcast, listeners should be able to:Recognize the impact of nutritional status on outcomes of critically-ill children.Describe the key aspects of the metabolic stress response in critical illness.Discuss a clinical approach to accurately estimating and prescribing nutrition in critically-ill children.Reflect on an expert's approach to managing aspects of nutrition in critically-ill children where there may not be high-quality evidence. Selected references:Mehta et al. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Pediatric Critically Ill Patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition. JPEN J Parenter Enteral Nutr. 2017 Jul;41(5):706-742. doi: 10.1177/0148607117711387. Epub 2017 Jun 2. PMID: 28686844. Fivez et al. Early versus Late Parenteral Nutrition in Critically Ill Children. N Engl J Med. 2016 Mar 24;374(12):1111-22. doi: 10.1056/NEJMoa1514762. Epub 2016 Mar 15. PMID: 26975590.Questions, comments or feedback? Please send us a message at this link (leave email address if you would like us to relpy) Thanks! -Alice & ZacSupport the showHow to support PedsCrit:Please complete our Listener Feedback SurveyPlease rate and review on Spotify and Apple Podcasts!Donations are appreciated @PedsCrit on Venmo , you can also support us by becoming a patron on Patreon. 100% of funds go to supporting the show. Please remember that all content during this episode is intended for educational and entertainment purposes only. It should not be used as medical advice. The views expressed during this episode by hosts and our guests are their own and do not reflect the official position of their institutions. If you have any comments, suggestions, or feedback-you can email us at pedscritpodcast@gmail.com. You can also check out our website at http://www.pedscrit.com. Thank you for listening to this episode of PedsCrit!

Sonal N. Shah, MD, MPH, Division of Emergency Medicine, Boston Children's Hospital, Harvard Medical School, discusses the Rational Clinical Examination article "Has This Child Experienced Physical Abuse?" with JAMA Associate Editor David L. Simel, MD, MHS. Related Content: Has This Child Experienced Physical Abuse?

Selbst geringe Mengen Alkohol bergen gesundheitliche Risiken. Bereits zwei kleine alkoholische Getränke pro Woche gelten laut aktuellen Empfehlungen als Obergrenze für einen risikoarmen Konsum. Ein völliger Verzicht ist aus medizinischer Sicht aber am gesündesten. In der aktuellen Folge von "Aha! Zehn Minuten Alltagswissen" geht es um die gesundheitlichen Risiken von Alkohol und die Frage, ob Phasen der Abstinenz wie der "Dry January" tatsächlich etwas bringen. Zu Gast ist die Ernährungswissenschaftlerin Margrit Richter, stellvertretende Leiterin des Referats Wissenschaft der Deutschen Gesellschaft für Ernährung (DGE). Außerdem gehen wir dem Phänomen Doomscrolling auf den Grund. WHO, keine unbedenkliche Menge bei Alkohol: https://www.who.int/europe/de/news/item/28-12-2022-no-level-of-alcohol-consumption-is-safe-for-our-health Harvard Medical School: https://www.health.harvard.edu/mind-and-mood/doomscrolling-dangers "Aha! Zehn Minuten Alltags-Wissen" ist der Wissenschafts-Podcast von WELT. Wir freuen uns über Feedback an wissen@welt.de. Produktion: Sermet Agartan Redaktion: Wiebke Bolle Impressum: https://www.welt.de/services/article7893735/Impressum.html https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

I am thrilled to reconnect with Nick Norwitz today. Nick is a researcher and educator with a mission to make metabolic health a mainstream concern. He graduated valedictorian from Dartmouth College, completed his PhD in metabolism at the University of Oxford, and earned his MD at Harvard Medical School. He has become known as a clinical researcher and metabolic health educator, speaking and writing on various topics, including brain health, microbiome, mitochondrial function, cholesterol, and more.  In our conversation, we discuss the challenges of providing evidence-based medicine, and Nick shares his personal story of overcoming inflammatory bowel disease with a ketogenic diet. We explore the research on statins reducing endogenous GLP-1 production, highlighting the importance of staying curious. We also clarify the different types of type 2 diabetes, the effects of biomolecular aging, and different perspectives on Lp(a).  Nick always provides thoughtful and valuable insights on a range of topics. His Substack is one of my favorites, sharing several ways to enhance your learning process, as a clinician or a layperson. IN THIS EPISODE, YOU WILL LEARN: How his struggle with inflammatory bowel disease led Nick to realize that the evidence-based care of western medicine is not always the best type of care, and how a ketogenic diet saved his life How a recent study highlighted several major physical issues statins cause, yet it went largely unnoticed in medicine and the media The need for clinicians to inform their patients about the potential side effects of their medications How physicians tend to ignore evidence in favor of one-sided messaging that erodes trust and undermines informed care The importance of remaining curious and acknowledging that what you learned initially might be incorrect How technological advances will make personalized medicine the future of healthcare The limitations of traditional one-size-fits-all randomized controlled trials The sub-phenotypes of type 2 diabetes How enzyme inhibitors (like statins) disrupt the gut microbiome How metabolic health and oxidative stress affect Lp(a), and how vitamin C can potentially reduce its impact Bio: Nick Norwitz Nick Norwitz, MD, PhD, is a researcher-educator whose mission is to “Make Metabolic Health Mainstream.” He graduated Valedictorian from Dartmouth College, majoring in Cell Biology and Biochemistry, before completing his PhD in Metabolism at the University of Oxford and his MD at Harvard Medical School.  Nick has made a name for himself as a clinical research and metabolic health educator, speaking and writing on topics ranging from brain health, the microbiome, and mental health to muscle physiology, mitochondrial function, and cholesterol and lipids. His mantra is “Stay Curious.” Connect with Cynthia Thurlow   Follow on X, Instagram & LinkedIn Check out Cynthia's website Submit your questions to support@cynthiathurlow.com Connect with Nick Norwitz On YouTube, X, and Instagram His Substack

What happens when an emergency medicine physician knows that the N95 mask she's wearing every day during the COVID-19 pandemic was invented by her great-grandfather over a century ago? Dr. Shan Liu joins me for a conversation that weaves together family legacy, innovation from the margins, and the power of storytelling to fight racism. Shan is an emergency medicine physician at Mass General Hospital, an associate professor at Harvard Medical School, and a children's book author. Her award-winning book, Masked Hero: How Wu Lien-teh Invented the Mask That Ended an Epidemic, tells the remarkable story of her great-grandfather who created the first respiratory mask during the 1910 Manchurian plague outbreak. Wu Lien-teh was the first Chinese Malaysian to study medicine at Cambridge, faced relentless racism throughout his career, and became the first Chinese person nominated for a Nobel Prize in medicine. Website: shanwuliu.com If you enjoy the show, please leave a ⭐⭐⭐⭐⭐ rating on Apple or a

Does parenting sometimes feel overwhelming or chaotic? In this episode, Dr Chris Willard shares how mindfulness, humor, and small daily practices can shift the tone of your home and build resilience for kids. He explains why calm begins with you and how presence matters more than perfection. Listen now to discover one simple shift that can bring more peace and connection into your family life.What to expect in this episode:Dr Chris Willard's journey with ADHD, sobriety, and mindfulnessMindfulness as play, humor, movement, and creativityHow a few breaths can calm the body and sharpen focusWhy parent regulation shapes child regulationSimple daily tools to reset stress and restore connectionAbout Christopher Willard, PsyDDr. Christopher is a clinical psychologist, author, and consultant based in Massachusetts. He teaches at Harvard Medical School and has shared his expertise on mindfulness and mental health in over forty countries, including two TEDx events. Dr. Willard is the author of twenty books, such as Alphabreaths (2019), Growing Up Mindful (2016), Feelings Are Like Farts (2023), and College Mental Health 101 (2025). His work has been featured in The New York Times, The Washington Post, mindful.org, CNN.com, and many other outlets.  Connect with Dr. ChristopherWebsite: Dr. Christopher Willard Instagram: @drchriswillardRelated Links: Helping Young Adults Get Back On Track https://impactparents.com/helping-young-adults-get-back-on-track The Power of Good Enough: Progress Over Perfection https://impactparents.com/the-power-of-good-enough-progress-over-perfectionSimplifying Mindfulness (and How to Start Small) https://impactparents.com/simplifying-mindfulness-and-how-to-start-small Get your FREE copy of 12 Key Coaching Tools for Parents at https://impactparents.com/podcastgift Read the full blog here:https://impactparents.com/fun-simple-mindfulness-for-adhd-families-with-dr.-chris-willard Connect with Impact Parents:Instagram: https://www.instagram.com/impactparentsFacebook: https://www.facebook.com/ImpactParentsLinkedIn: https://www.linkedin.com/company/impactparentsSponsors"Cognitive Ergonomics from the Inside Out" – A New ADHD InterventionDo you recognize current ADHD interventions fall short? At DIG Coaching, we've developed a groundbreaking field of engineering called Cognitive Ergonomics from the Inside Out. Discover a fresh approach to ADHD care that looks beyond traditional methods.Learn more at www.cognitive-ergonomics.com

Synopsis: This episode is proudly sponsored by Quartzy. In this far-reaching conversation, Rahul Chaturvedi speaks with John Lepore, CEO & President of ProFound Therapeutics and CEO-Partner at Flagship Pioneering, tracing a career shaped by a deep commitment to understanding the causal machinery of human disease. John shares how a Harvard-trained physician-scientist evolved into a biotech leader building one of the industry's most ambitious platform companies. Reflecting on 17 years at GSK — from academic cardiologist to running global research — John describes the moment he realized traditional target discovery had reached its limits. That insight propelled him into Flagship's venture-creation ecosystem and ultimately into leading ProFound Therapeutics, where the team is uncovering tens of thousands of previously unknown human proteins that could fundamentally reshape drug discovery and unlock true first-in-class opportunities. John also offers a candid look at today's biotech leadership realities: navigating capital-tight markets, fostering high-trust pharma partnerships, making disciplined early kill decisions, and using AI to extract causal insights from vast proteomic datasets. Together, he and Rahul explore why the expanded human proteome may be medicine's next great frontier — and what it takes, scientifically and psychologically, to lead a company bold enough to pursue it. Biography: John Lepore, M.D., is CEO and President of ProFound Therapeutics and CEO-Partner at Flagship Pioneering, where he is leading a new era of drug discovery by harnessing the expanded proteome to build a pipeline of first-in-class medicines. A physician-scientist and accomplished pharma executive, he joined ProFound following a 17-year career at GSK, where he was most recently SVP, Head of Research, leading a 2,500+ person global team and driving a renewed focus on immunology and human genetics across target discovery and validation, modality platforms, drug discovery, and clinical translation. He also chaired GSK's Research Review and Investment Board, guiding capital allocation and R&D strategy. Under his leadership, GSK advanced 15 Phase 1 programs with first- or best-in-class potential and executed $1B+ in strategic R&D deals. Before joining the biopharma industry, Dr. Lepore was a faculty cardiologist and research investigator at the University of Pennsylvania, where his lab investigated the transcription regulation of cardiovascular development. He currently serves on the boards of ProFound, KSQ Therapeutics, and the Innovation Growth Board of Mass General Brigham. Dr. Lepore received his B.S. in Biology from the University of Scranton and his M.D. from Harvard Medical School, after which he completed his residency and post-doctoral training at Massachusetts General Hospital and the Harvard School of Public Health.

We rely on our memories for so much. Memory is the foundation of our sense of self, ability to learn new information, and stay safe. But our memories are also highly suggestible, and we often misremember events or fabricate memories entirely. In this episode, host Samantha Laine Perfas talks with science researcher Dan Schacter, Alzheimer's expert Margaret O'Connor, and neuroscientist Venki Murthy about the science of memory – and how we can remember better.

Stay ahead in NSCLC management with this accredited podcast! HER2 alterations, including gene mutations and protein overexpression, are key therapeutic targets, but their complexity can challenge treatment decisions. In Module 1 of this podcast, Dr. Julia Kathleen Rotow, Clinical Director of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute and Assistant Professor of Medicine at Harvard Medical School, provides essential insights and testing recommendations to optimize patient care. Listen now! Click here to claim CME/NCPD credit: bit.ly/49NCaQu

Stay ahead in NSCLC management with our accredited podccast! HER2 alterations, including gene amplifications, mutations, and protein overexpression, are critical therapeutic targets, but their heterogeneity can complicate treatment strategies. In Module 2, Dr. Julia Kathleen Rotow, Clinical Director of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute and Assistant Professor of Medicine at Harvard Medical School, explores advanced testing methodologies and strategies to navigate HER2 complexities and optimize patient outcomes. Listen now! Click here to claim CME/NCPD credit: bit.ly/405xEJO

Sleep shapes your mood, memory, immune system, and long-term health, yet most of us aren't getting enough. Harvard Medical School and Mass General Brigham sleep scientist Dr. Elizabeth Klerman shares the three easiest science-backed changes proven to improve your sleep tonight, plus the myths that make things worse.  If you're struggling to fall asleep, waking at 3 a.m., or dragging through the day, this episode is for you. 

What happens when midlife burnout becomes a full-body and mindset revolution? In episode 238 of Joy Found Here, certified coach Terry Tateossian shares how she went from 80 pounds overweight and pre-diabetic to rebuilding her life inside and out. Her story isn't just about weight loss—it's about unlearning old conditioning, finding strength through science, and proving that transformation at any age is entirely possible.In This Episode, You Will Learn:Immigrant roots and early body beliefs (04:02)Overwork, crash diets, and collapse (06:53)Chest pains and wake-up calls (08:28)Epigenetics and generational healing (10:40)Why diets don't work (15:34)Building strength and self-trust (18:04)Redefining progress beyond the scale (25:13)Mastering macros and protein (32:14)Hormones, muscle, and midlife power (38:05)From marshmallow to momentum (47:14)Terry Tateossian is a certified Lifestyle Medicine Coach, Nutritionist, and Personal Trainer who helps women navigate midlife with strength and balance. As the founder of The House of Rose, she blends science, mindset, and holistic wellness to transform how women relate to their bodies and habits. With certifications from Harvard Medical School and a background in business, she leads global retreats and coaching programs that focus on sustainable health and empowerment. Her own transformation—from 80 pounds overweight and pre-diabetic to thriving athlete—drives her mission to redefine midlife wellness.In this episode, Terry shares how a series of health scares pushed her to break free from generational beliefs around food and body image. Through holistic medicine, epigenetics, and strength training, she learned that true healing starts with awareness, not restriction. She dismantles the myth of “quick-fix” diets, explains why the scale tells only part of the story, and shows how understanding macros and hormones can change everything. With honesty and humor, Terry reminds listeners it's never too late to rebuild health—and self-worth—from the inside out.Connect with Terry Tateossian:Thor WellnessInstagramLinkedInFacebookLet's Connect:WebsiteInstagram Hosted on Acast. See acast.com/privacy for more information.

Description: Psoriatic disease affects far more than just the skin. Hear leading dermatologist Dr. April Armstrong and Dr. Benoît Guérrette discuss this and more with Jensen, a patient advocate. Psoriatic disease affects not only the skin but it can impact confidence, emotional and social well-being, and daily life. In this episode, join moderator Dr. Guy Eakin, Chief Scientific and Medical Officer at NPF, as we explore the disconnect between clinical classifications of psoriasis and what patients experience in real-life with leading dermatologist Dr. April Armstrong, Dr. Benoît Guérrette, Vice President of Dermatology & Rheumatology at Takeda, and Jensen, a NPF patient advocate and former Lead Youth Ambassador. Listen as we address the need for a more nuanced approach to classifying disease severity that accounts for the holistic needs of psoriatic disease, as well as share insights into how advocacy and awareness can drive change in treatment access and care standards.  The intent of this episode is to identify how clinical severity classifications of psoriasis are evolving to meet the needs of those who live with the disease and how that change impacts overall management. This episode is sponsored by Takeda. Timestamps: (0:00) Intro to Psoriasis Uncovered and guest welcome to dermatologist Dr. April Armstrong, Vice President of Takeda, Dr. Benoît Guérette, and patient advocate Jensen, who discuss the unmet needs of people with moderate psoriasis and how as a community we can better serve those living with the disease. 2:22 How health care providers and the biopharmaceutical industry are coming together to address systemic eligibility and the unmet needs of people living with psoriasis. 4:25 Quality of life should be included when assessing clinical severity in psoriasis and identification of appropriate treatment choices. 6:52 The impact of misdiagnosis, inappropriate treatment, and effect on high impact sites can be life- altering. 8:30 How appropriate treatment and knowledge can make all the difference when diagnosed with plaque psoriasis.  9:40 Views on the psoriasis disease classification system and how it's evolving to include real life impact from physical and emotional needs, to more personalized care for those living with psoriasis, even when small body surface areas are involved. Severity isn't defined by skin coverage alone. 12:38 What's needed to prioritize the care and outcomes of people living with psoriasis. 14:18  The future of management and care for psoriatic disease. 15:53  "My skin tells a story." Wisdom from what I wish I had known previously. 16:52  Moving closer to care that truly reflects the lives and needs of those who live with psoriasis. Key Takeaways: ·       Severity of psoriasis isn't defined by skin coverage or body surface area (BSA) alone. The impact on quality of life should also be considered in the assessment, selection of treatment, and management of the disease.  ·       The psoriasis disease classification system is evolving to be more of a patient centered approach.  Many clinicians are now using the International Psoriasis Council (IPC) or 2 bucket approach to identify whether someone should receive a topical or systemic treatment based on location and response to treatment, as well as impact on quality of life.  ·       With continued research and  development, the next 5 to 10 years could see a shift in effective treatment options while also treating sooner to initiate better outcomes for people living with psoriasis and psoriatic arthritis. Guest Bios:   April Armstrong, M.D., M.P.H. is an internationally renowned dermatologist and clinical researcher who is a Professor and Chief of Dermatology at the University of California Los Angeles (UCLA) where she specializes in inflammatory skin diseases such as psoriasis, atopic dermatitis, and hidradenitis suppurativa (HS). Dr. Armstrong is also the Co-Director for Network Resources at the UCLA Clinical and Translational Research Institute. She has conducted over 150 clinical trials and published over 350 high impact articles in scientific journals. Dr. Armstrong holds multiple leadership positions including the immediate Past Chair of the National Psoriasis Foundation Medical Board, Co-President of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), councilor for the International Psoriasis Council, and board member for the International Dermatology Outcome Measures and the American Academy of Dermatology.  Benoît Guérette, Ph.D. is an accomplished leader in medical affairs with extensive experience across academia and the pharmaceutical industry. Since March 2025, Dr. Guérette has served as Vice President of Dermatology and Rheumatology US Medical Affairs at Takeda Pharmaceutical. Prior to joining Takeda, he held several strategic and leadership roles at various pharmaceutical companies, including overseeing clinical development, global and U.S. medical affairs, global access & pricing, translational sciences and more. Before transitioning to the industry, Dr. Guérette was an Associate Professor of Immunology at Laval University, leading research in cancer immunology. He holds a Ph.D. in Medicine, Microbiology, and Immunology from Laval University and completed postdoctoral studies in Inflammation and Immunology at  Harvard Medical School.  Jensen is a volunteer and former Lead Youth Ambassador for the National Psoriasis Foundation. Jensen developed psoriasis at age 7 but wasn't formally diagnosed until age 14 being misdiagnosed along the way, trying different management approaches that were ineffective. She was a competitive swimmer from elementary through high school and in the last 2 years of high school played lacrosse. Upon finishing high school she attended college becoming a registered nurse in an intensive care unit. Jensen wants "youth living with psoriatic disease to feel a  community that is behind them and with them every step of the way. I really want to be able to make a difference in a way that would've helped me as a child when I was diagnosed." Resources: Ø  "Reassessing Psoriasis Severity" Advance Online, National Psoriasis Foundation. H. Onorati. January 16, 2024,  https://www.psoriasis.org/advance/psoriasis-severity-high-impact-sites/   Ø  "Psoriasis Involving Special Areas is Associated with Worse Quality of Life, Depression, and Limitations in the Ability to Participate in Social Roles and Activities". Blauvelt, A., Strober, B., Gondo, G., Journal of Psoriasis and Psoriatic Arthritis Volume 8, Issue 3.  https://journals.sagepub.com/doi/full/10.1177/24755303231160683

In episode 62 of Going anti-Viral, Dr Rochelle Walensky joins host Dr Michael Saag on World AIDS Day 2025 to discuss her experience as the Director of the Centers for Disease Control and Prevention (CDC) during the COVID-19 pandemic and the current state of public health in the United States. Dr Walensky is a Professor of Medicine at Harvard Medical School and has published over 300 research articles that have motivated changes to US HIV testing and immigration policy and promoted expanded funding for HIV-related research, treatment, and the President's Emergency Plan for AIDS Relief (PEPFAR). Dr Walensky reflects on her experience during the early months of the COVID-19 pandemic in Massachusetts where she was the Chief of the Division of Infectious Diseases at Massachusetts General Hospital. Dr Saag and Dr Walensky then discuss her transition to the Director of the CDC and her management of the agency during the pandemic. Dr Walensky and Dr Saag emphasize the dedication of public health professionals and the need for continued support and understanding of the challenges they face. They discuss the risk of proposed budget cuts to the CDC and the impacts this will have on the agency as well as state and local public health departments. Finally, they discuss the future of public health and their shared optimism for public health over the long-term.0:00 – Introduction1:41 – Management of the early outbreak of COVID-19 in Massachusetts and reflections on the Conference on Retroviruses and Opportunistic Infections (CROI) in March of 202011:50 – Transition to lead the CDC and reflections on the difficult job of management of the CDC during a pandemic24:00 – Navigating COVID-19 variants and the challenge of public health recommendations for wearing masks and vaccination28:24 – Outlook on the future of public health and the CDC and the risks of proposed budget cuts on state and local public health agencies __________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...

Guest: Dr. Anderson is currently the Albert H. Coons Professor of Neurology at Harvard Medical School, Senior Scientist at the Brigham and Women's Hospital, Institute Member of the Broad Institute of MIT and Harvard, and Core Faculty Member of the Gene Lay Institute of Immunology and Inflammation. She talks about her research on immune regulation in cancer and enhancing anti-tumor immunity. (38:33) Featured Products and Resources: Submit your abstract now for IMMUNOLOGY2026! Download a free wallchart on the production of CAR T cells. The Immunology Round Up CAR Tregs for Atherosclerosis: Anti-oxidized low-density lipoprotein CAR Tregs reduce atherosclerotic plaque formation in mouse models. (2:20) Tumor-Reactive T Cells: Tumor-reactive CD8+ T cells can be isolated and expanded from clinical samples. (14:24) Harnessing Myeloid and Lymphoid Synergy for Immunotherapy: Myeloid-targeted immunocytokines and natural killer/T cell enhancers show potential for treating solid cancers. (18:50) Subcutaneous Fat Affects Intestinal Aging: Subcutaneous white adipose tissue dysfunction triggers aging-like intestinal dysfunctions in mouse models. (32:40) Subscribe to our newsletter! Never miss updates about new episodes. Subscribe

Is exercise the ultimate catalyst for brain development, learning, and performance? The evidence is clear: exercise and brain performance are intrinsically linked. From resistance training to aerobic workouts, exercise physically transforms our brains, enhances performance and serves as our strongest defense against mood disorders, Alzheimer’s, ADHD, and addiction. This week on Krush Performance, we dive deep with Dr. John Ratey, renowned author and Associate Clinical Professor of Psychiatry at Harvard Medical School. We explore “A User’s Guide to the Brain” and delve into “Spark: The Revolutionary New Science of Exercise and the Brain.” Unlock your mental potential to conquer stress, sharpen your thinking, elevate your mood, boost your memory, and elevate your performance to new heights. Join us for this compelling conversation about the brain-body connection—a vital relationship in Creating More Coachable Players. Tune in and transform your approach to player development. The 20th season of Krush Performance is in full swing! Have a favorite guest or topic you'd like us to revisit? Or a burning issue you want us to investigate? Let us know at jeffkrushell.com. While you're there, subscribe to the Krush podcast and sign up for our weekly newsletter to stay on the cutting edge of human performance. Subscribe to the show on Apple Podcasts, Spotify, iHeartRadio, and TuneIn Radio! Don't forget to rate and review the show! Follow @JeffKrushell for weekly updates, show notes, and behind-the-scenes insight from Krush's CREATING COACHABLE PLAYERS PROGRAM. E-Mail Jeff with your questions and comments for the show and don't forget to visit KrushPerformance.com for live streaming, blogs, links, and so much more The post Episode 25-21: The User’s Guide to the Brain & Spark Dr. John Ratey appeared first on Radio Influence.

Send us a textMost people think memory loss is a downhill slide you can't stop. We don't. In this conversation with neurologist and neuroscientist Dr. Majid Fotuhi, we map out a twelve‑week blueprint that measurably improves memory, focus, and even grows hippocampal volume by targeting the real drivers of decline: poor sleep, chronic stress, insulin resistance, hearing loss, inactivity, and hidden medical issues.Dr. Majid Fotuhi is a pioneering neurologist, neuroscientist, and professor with more than thirty-five years of experience in brain health, memory, neuroplasticity, and the prevention of Alzheimer's disease. His work bridges research, clinical innovation, and public education.He earned his PhD in neuroscience from Johns Hopkins University, completed medical training at Harvard Medical School, and returned to Johns Hopkins for his neurology residency. He currently serves as an adjunct professor at Johns Hopkins University.An author and communicator, Dr. Fotuhi has written several books and is known for making complex science accessible. His excellence in teaching earned him the American Academy of Neurology's prestigious award. His research has appeared in peer-reviewed journals, been presented at major conferences, and cited widely by scientists worldwide.Dr. Fotuhi has created a twelve-week program that has helped thousands of patients with memory loss, brain fog, concussion, mild cognitive impairment, and early Alzheimer's disease. His expertise has been featured by CNN, NBC News, the Today Show, ABC News, The New York Times, The Washington Post, and The Times (London).We start by clarifying what mild cognitive impairment is, how it differs from dementia, and why so many cases are preventable. Dr. Fotuhi explains the “type 3 diabetes” model—how decades of sugar spikes and inflammation erode the blood‑brain barrier and starve neurons of a stable environment. Then we get practical. You'll hear how a personalized “brain portfolio” guides treatment: VO2 max testing to shape exercise, sleep studies and CPAP when needed, targeted brain training that matches deficits, and labs for vitamin D, B12, and omega‑3 status. The results? Early wins in two to three weeks, statistically significant gains at six and twelve, and habits that stick.We don't stop at diet and steps. Oral health impacts cognition by limiting whole foods and increasing inflammation; chewing itself engages neural circuits. Hearing loss quietly accelerates decline—hearing aids can move people from mild impairment back to normal. Add a simple, sustainable food approach—ditch ultra‑processed foods, eat vegetables, legumes, fruits, quality proteins, and healthy fats—and consider targeted supplementation with DHA/EPA omega‑3s and corrected D and B12 levels. Along the way, we address why amyloid hogged the spotlight, and point to powerful data: the Lancet's estimate that 45% of dementia cases are preventable and the American Heart Association's claim that 80% of strokes can be avoided.If you want a sharper brain by summer, this is your starting line. Subscribe, share this with someone you love, and leave a review telling us the one habit you'll change this week. Your future brain will thank you.Links:Majid Fotuhi, MD, PhD: https://drfotuhi.com/https://krieger.jhu.edu/mbi/directory/majid-fotuhi/https://neurogrow.com/about-us/dr-majid-fotuhi-md-phd/https://psychology.columbian.gwu.edu/majid-fotuhiTweet me @realdrhamrahIG @drhamrah

Enid Martinez, MD is a Senior Associate in Critical Care at Boston Children's Hospital, and an Assistant Professor of Anaesthesia at Harvard Medical School. She is the Director of the Pediatric Critical Care Nutrition Program in the Division of Critical Care Medicine and Principal Investigator for a clinical-translational research program on gastrointestinal function and nutrition in pediatric critical illness. Learning Objectives:By the end of this podcast, listeners should be able to:Recognize the impact of nutritional status on outcomes of critically-ill children.Describe the key aspects of the metabolic stress response in critical illness.Discuss a clinical approach to accurately estimating and prescribing nutrition in critically-ill children.Reflect on an expert's approach to managing aspects of nutrition in critically-ill children where there may not be high-quality evidence. Selected references:Mehta et al. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Pediatric Critically Ill Patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition. JPEN J Parenter Enteral Nutr. 2017 Jul;41(5):706-742. doi: 10.1177/0148607117711387. Epub 2017 Jun 2. PMID: 28686844. Fivez et al. Early versus Late Parenteral Nutrition in Critically Ill Children. N Engl J Med. 2016 Mar 24;374(12):1111-22. doi: 10.1056/NEJMoa1514762. Epub 2016 Mar 15. PMID: 26975590.Questions, comments or feedback? Please send us a message at this link (leave email address if you would like us to relpy) Thanks! -Alice & ZacSupport the showHow to support PedsCrit:Please complete our Listener Feedback SurveyPlease rate and review on Spotify and Apple Podcasts!Donations are appreciated @PedsCrit on Venmo , you can also support us by becoming a patron on Patreon. 100% of funds go to supporting the show. Thank you for listening to this episode of PedsCrit. Please remember that all content during this episode is intended for educational and entertainment purposes only. It should not be used as medical advice. The views expressed during this episode by hosts and our guests are their own and do not reflect the official position of their institutions. If you have any comments, suggestions, or feedback-you can email us at pedscritpodcast@gmail.com. Check out http://www.pedscrit.com for detailed show notes. And visit @critpeds on twitter and @pedscrit on instagram for real time show updates.

In today's episode, we had the pleasure of speaking with Jacob Sands, MD, and Shailee Shah, MD, about considerations for diagnosing and managing Lambert-Eaton myasthenic syndrome (LEMS), particularly in the context of small cell lung cancer (SCLC). Dr Sands is associate chief of the Lowe Center for Thoracic Oncology and the Oncology Medical Director of the International Patient Center at Dana-Farber Cancer Institute, as well as an assistant professor at Harvard Medical School in Boston, Massachusetts. Dr Shah is a clinical assistant professor of neurology (MS/neuroimmunology) at the Northwestern University Feinberg School of Medicine in Chicago, Illinois.  In our exclusive interview, Drs Sands and Shah discussed LEMS symptom identification, the importance of paraneoplastic panels for assessing neurologic dysfunction in patients with SCLC, the need for specific autoantibody testing, and what guidelines currently note as best practices for the diagnosis of this disease. 

German-born spiritual teacher and self-help author Eckhart Tolle once wrote, "Acknowledging the good that you already have in your life is the foundation for all abundance."  I found this to be true in my life as well, and as it turns out, expressing gratitude isn't just a sound spiritual practice. It's essential to our emotional and physical well-being.  According to a recent study performed at Harvard Medical School, "Gratitude is strongly and consistently associated with greater happiness. Gratitude helps people feel more positive emotions, relish good experiences, improve their health, deal with adversity, and build strong relationships."    How can you reap the benefits? While there are many beneficial exercises that can help you cultivate an attitude of gratitude, such as journaling, morning or evening reflections, and performing acts of kindness, many people focus their thoughts outward (Ex: I'm grateful for my children, a roof over my head, my job, etc.).It's easy to lose sight of the good in ourselves. Instead, let's focus inward. Tune in as Anthony and I share what we're grateful for about each Enneagram type and why you should be too.

This week we go back in time to 2020 to delve into the topic of fellow wellness and review a work from the Boston Children's group on fellow fears and stressors when beginning their training. Are there patterns amongst the fellow concerns that can be identified and used to inform interventions to help allay these fears and reduce the stress? We speak with Dr. David Brown, Associate Professor of Pediatrics, Harvard Medical School and also Dr. Tony Pastor who was then the ACHD Fellow at Boston Children's Hospital/Brigham and Women's Hospital about their thoughts on fellow fears and stressors as well as fellow (and doctor) wellness. doi: 10.1007/s00246-019-02276-z.

Happy Thanksgiving, gentlemen!In this Manlihood Thanksgiving Special, Josh dives deep into gratitude—what it is, what it isn't, why it matters, and how building a thankful mindset can shape stronger, healthier, more resilient men. This episode includes science-backed benefits, real talk about entitlement and complaining, powerful quotes, personal reflections, and a guided gratitude meditation to help you reset your heart and mind.If you need encouragement today—or want a new perspective on gratitude—you're in the right place.00:00 — Welcome + Thanksgiving intro01:00 — Why Thanksgiving is Josh's favorite tradition01:40 — Gratitude as an intentional practice02:10 — What gratitude really is: posture, mindset, discipline02:45 — How gratitude rewires your brain (UC Davis study)03:00 — Dopamine, motivation, and the science behind gratitude03:20 — APA: Gratitude reduces anxiety & depression03:40 — Harvard Medical School on sleep, immune function, stress resilience04:10 — Gratitude isn't weak — it's mental strength training04:30 — The opposites of gratitude04:45 — Entitlement: “I deserve this”05:10 — Complaining: “This isn't enough”05:30 — Taking things for granted06:00 — Quotes on gratitude from Aesop, David Steindl-Rast, Marcus Aurelius, and 1 Thess 5:1806:45 — Who are you grateful to?07:20 — Directing your gratitude toward real people07:45 — Josh's family Thanksgiving tradition08:00 — What Josh is thankful for this year10:00 — Gratitude for the Manlihood community10:30 — The Thanksgiving Weekend Gratitude Challenge11:00 — Guided Gratitude Meditation12:00 — Identifying something you're grateful for13:00 — Identifying someone you're grateful for13:30 — Being grateful for growth in yourself14:00 — Final Thanksgiving message & encouragement15:00 — Closing thoughts: Gratitude is a way of livingConnect with other men who want to grow, lead, and live with purpose.

Clinicians should weigh benefits against risks when engaging patients in informed discussions about cannabis or cannabinoid use. Kevin Hill, MD, MHS, of Harvard Medical School joins JAMA Senior Editor Karen Lasser, MD, MPH, to discuss the current evidence about the therapeutic use of cannabis and cannabinoids in adults, potential harms, and evidence-based clinical guidance. Related Content: Therapeutic Use of Cannabis and Cannabinoids

In this episode of More Than A Pretty Face, Dr. Azi speaks with Dr. Tomi Wall about modern rosacea management, including pulsed-dye lasers, V-Beam, combination treatments, and intradermal Botox for flushing. She then sits down with Dr. Monica Boen to discuss the resurgence of CO₂ and Erbium resurfacing lasers, evolving technology, and the cautious excitement around regenerative treatments like exosomes and PDRN. Both dermatologists share practical skincare advice, treatment philosophy, and their go-to in-office approaches for natural, effective results.  Timeline of what was discussed: 00:00 – Podcast intro & welcome 00:07 – Introducing Dr. Tomi Wall 00:55 – Why rosacea emotionally affects patients 01:40 – Types of rosacea explained 02:35 – Top at-home treatments (azelaic acid, ivermectin, sulfur) 03:40 – In-office vascular treatments with PDL 04:40 – How vascular lasers improve rosacea 05:25 – V-Beam for scarring 06:15 – Best timing to start scar laser treatment 07:15 – Treating bruising immediately after filler 08:10 – V-Beam settings for bruising 09:00 – Botox for flushing & neurovascular mechanisms 10:00 – Dilution, dosing, safety precautions 11:05 – Topicals for temporary redness & rebound effects 12:00 – Rapid-fire questions 13:25 – Close of interview 1 15:25 – Introducing Dr. Boen & her practice 15:55 – Why CO₂ & Erbium ablative lasers are returning 16:35 – What ablative lasers do & why patients accept downtime 17:25 – UltraPulse CO₂ & Erbium for deep resurfacing 18:10 – UltraClear: lighter resurfacing with minimal downtime 19:10 – Choosing mild vs aggressive resurfacing settings 19:55 – Combination treatments (Pico, PDL, Fraxel, Clear & Brilliant) 20:40 – PDRN ("salmon DNA"): buzz vs data 21:40 – Exosomes: potential & regulatory concerns 22:50 – Real complications seen from unregulated injectables 23:35 – Dr. Boen's personal favorite treatments 24:10 – Daily skincare must-haves (SPF, retinoids, antioxidants) 25:00 – LED masks: when they help and when they don't 25:55 – Final message: patient education matters 26:40 – Podcast closing & where to submit questions   ______________________________________________________________ Follow Tomi Wall on Instagram: @dr.tomileewall Dr. Tomi Wall is a laser fellowship–trained, board-certified dermatologist based in Northern California. With advanced training from Harvard Medical School and extensive experience teaching residents at Stanford, she specializes in vascular and laser-based treatments for rosacea, scarring, and inflammatory skin conditions. Dr. Wall is known for her research-informed approach, dedication to patient-centered care, and expertise in combination therapy to achieve natural, evidence-based outcomes.   Follow Monica Boen on Instagram: @drmonicaboen Dr. Monica Boen is a board-certified dermatologist practicing in San Diego with advanced specialization in aesthetic and procedural dermatology. Trained in ablative and regenerative laser surgery, she is recognized for bringing modern innovation to legacy resurfacing technologies such as CO₂ and Erbium lasers. Dr. Boen is known for her comprehensive treatment planning, commitment to clinical safety, and ability to blend multiple modalities for powerful yet natural skin rejuvenation results. ______________________________________________________________ Submit your questions for the podcast to Dr. Azi on Instagram @morethanaprettyfacepodcast, @skinbydrazi, on YouTube, and TikTok @skinbydrazi. Email morethanaprettyfacepodcast@gmail.com. Shop skincare at https://azimdskincare.com and learn more about the practice at https://www.lajollalaserderm.com/ The content of this podcast is for entertainment, educational, and informational purposes and does not constitute formal medical advice. © Azadeh Shirazi, MD FAAD.  

In this episode, host Shikha Jain, MD, speaks with Amy Comander, MD, about incorporating lifestyle medicine into cancer care, exciting advancements highlighted at the 2025 San Antonio Breast Cancer Symposium and more. •    Welcome to another exciting episode of Oncology Overdrive 1:02 •    About Comander 1:16 •    The interview 3:42 •    How do you find time to do everything that you do? 4:06 •    When you started on your path, did you see your journey taking you to breast cancer, lifestyle medicine and authorship? How did you get to where you are today? 4:34 •    Jain and Comander on the shifting mindset toward holistic patient care. 6:36 •    Jain and Comander on the importance of lifestyle interventions in cancer care.  7:50 •    Jain and Comander discuss optimizing survivorship. 9:04 •    Tell us more about your latest book, PAVING Your Path Through Breast Cancer and Beyond […] What are you most excited about sharing from this book? 9:50 •    Do you feel like this is a book for physicians, patients, caregivers or everyone? 11:47 •    Is there anything related to lifestyle medicine, or breast oncology in general, that you are looking forward to hearing about at this year's San Antonio Breast Cancer Symposium? 14:38 •    What are your thoughts on ESMO's latest press release regarding mRNA COVID vaccines and improved response to immunotherapy? 17:29 •    Jain and Comander on specific lifestyle interventions to improve quality and quantity of life, as well as "guilty pleasures". 20:23 •    How do you train for all the marathons you run, and when do you find the time to train regularly? 21:43 •    What are the things that you are looking forward to seeing in the breast cancer space over the next decade in cancer care? 25:24 •    If someone could only listen to the last minute of this episode, what would you want listeners to take away? 27:37 •    How to contact Comander 28:45 •    Thanks for listening 29:42 Amy Comander, MD, DipABLM, FACLM, MSCP, is a breast oncologist and medical director of the Mass General Brigham Cancer Institute in Waltham, director of the lifestyle medicine program at the Mass General Brigham Cancer Institute, and an instructor in medicine at Harvard Medical School. You can get a copy of her new book, PAVING Your Path Through Breast Cancer, here. We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Comander can be reached on Instagram @dramycomander, LinkedIn, or via email acomander@mgh.harvard.edu. References •    Grippin AJ, et al. Nature. 2025;doi:10.1038/s41586-025-09655-y. •    PAVING the Path to Wellness. https://www.massgeneral.org/cancer-center/patient-and-family-resources/supportive-care/paving. Published 2021. Accessed November 11, 2026 Disclosures: Jain and Comander report no relevant financial disclosures. 

Our guest this time is Stephen Duclos, and his interest in aging is partly because he has been doing social change work for decades and sees aging as just one more civil rights horizon. He's also interested in aging because he's a sex therapist, and he sees all sex as queer sex when it comes to aging adults. Stephen has been working as a therapist and counselor since 1972. He currently holds licenses and national certifications in Sex Therapy (as a CST), Couples and Family Therapy (LMFT), Mental Health Counseling (LMHC), and Rehabilitation Counseling (CRC). Stephen is an Approved Supervisor with the American Association for Marriage and Family Therapists (AAMFT), and AASECT (the American Association of Sex Educators, Counselors, and Therapists). He is also a member of the American Family Therapy Academy. In 2012, he received the Patricia Schiller award from AASECT for his work on Fathers, Adolescent Daughters, and Sexuality. And in 2022, he was featured in a cover story in the NY Times Magazine about sex over 70. Jane first met Stephen at an AASECT conference and was immediately struck by his candor, and they have been teaching social workers and students of sex therapy ever since. He is always up for a new challenge and is one of the most thoughtful clinicians she knows. He has been a teacher and supervisor of therapists as an adjunct faculty member of UMass/Boston and is a principal faculty member in the Sex Therapy Training program at South Shore Sexual Health Center. He has also taught at Boston Medical Center and Harvard Medical School. He is vitally interested in intimacy, aging, fathers and daughters, and long-term sexual relationships.  Stephen has also been involved in civil rights work for more than 50 years. From registering voters for the Boston Election Commission in 1967, to helping establish the second Independent Living Center in the US for people with disabilities in the 1970s, to establishing biracial councils in the Boston Public Schools during desegregation through the late 1980s, to supporting liberation for the queer community, civil rights has been part of his ongoing, lifelong community work.   His interest in aging comes in large part from his commitment to being a therapist, seeing older clients, and threading the aging process in the tapestry of his own life. He is fierce, tender, brilliant, and a great teacher and learner. He wanted to expand his teaching practice by working with a sex educator, and Jane was so pleased that he invited her in because she loves teaching with him, always learning something new, as we did in this conversation.  Listeners, if you'd like to learn more about Stephen and his work, you can find more information here. If you want to catch up on other shows, just visit our website and please subscribe! We love our listeners and welcome your feedback, so if you love Our Better Half, please give us a 5-star rating and follow us on Facebook and Instagram. It really helps support our show! As always, thanks for listening!  

Overview This special episode of the Tick Boot Camp Podcast was recorded live at the 2nd Annual Alzheimer's Pathobiome Initiative (AlzPI) and PCOM Symposium in collaboration with Pathobiome Perspectives. Hosted by Ali Moresco in partnership with Nikki Schultek, Executive Director of AlzPI, the conversation brings the Tick Boot Camp mission of exploring infection-associated chronic illness (IACI)—including Lyme disease and other tick-borne infections—to the global Alzheimer's and neuroimmunology research community. Tick Boot Camp co-founders Matt Sabatello and Rich Johannesen partnered with Ali and Nikki to highlight leading scientists connecting infection, immune dysfunction, and cognitive decline. This episode features Dr. Sean Miller, a neuroscientist and co-investigator in the Logan Lab with a primary appointment at Yale School of Medicine, who is developing ways to non-invasively detect Alzheimer's-like pathology through the eye. Guest Sean Miller, PhD Co-Investigator, Logan Lab / Yale School of Medicine Dr. Sean Miller completed pre-doctoral work at Harvard Medical School, earned his PhD from Johns Hopkins University, and completed post-doctoral training at Stanford University. His research focuses on neurodegeneration, neuroglia, and early diagnostic strategies for Alzheimer's and related diseases. At the AlzPI & PCOM Symposium, Dr. Miller presented evidence showing that SARS-CoV-2 (COVID-19) infection can accelerate Alzheimer's-like pathology and that these changes can be detected non-invasively through retinal imaging. His findings suggest that amyloid-beta, a protein long associated with Alzheimer's disease, may also serve as part of the brain's antimicrobial defense system—trapping pathogens like a mesh or biofilm, but leading to damaging plaque buildup when overproduced. Key Discussion Points Dr. Miller describes how the COVID-19 virus can act as an infectious trigger for neuroinflammation and amyloid buildup, how the eye provides a unique window into the brain, and why early detection is essential to preventing neuron death. He shares how his lab's AI-enhanced retinal imaging research at Yale Eye Center is identifying amyloid and tau deposits in patients with long COVID-related brain fog—opening the possibility of routine eye exams doubling as early Alzheimer's screening tools. He explains potential therapeutic strategies, such as limiting amyloid production during infection flare-ups and enhancing clearance mechanisms afterward to reduce chronic plaque formation. The conversation also explores his scientific journey—from designing Alzheimer's drugs at Harvard and Johns Hopkins to realizing the need for early disease detection during his postdoc at Stanford—and how the pandemic inspired his focus on infection-induced neurodegeneration. “We believe neurons are exposed to pathogens in the central nervous system and respond by secreting amyloid-beta to trap them. Excessive plaque buildup from repeated or severe infections may be what drives long-term neurodegeneration.” — Dr. Sean Miller Why It Matters Dr. Miller's research connects infectious disease, ophthalmology, and neurology, providing a revolutionary new method to screen for early Alzheimer's-like changes non-invasively through the human eye. His work suggests that infections like COVID-19 may trigger the same protective—but damaging—immune responses implicated in chronic conditions such as Alzheimer's disease and infection-associated cognitive decline. About the Event The interview took place at the 2nd Annual Alzheimer's Pathobiome Initiative (AlzPI) and Philadelphia College of Osteopathic Medicine (PCOM) Symposium, held on October 3, 2025, at Ohio University in Dublin, Ohio. The event brought together more than 20 global researchers exploring how microbes, the microbiome, and the immune response contribute to Alzheimer's, dementia, PANS/PANDAS, and infection-associated chronic illnesses (IACI). Tick Boot Camp partnered with Ali Moresco and Nikki Schultek to share the voices of researchers advancing the field of infection-associated chronic illness. This episode is part of a multi-part Tick Boot Camp series highlighting how pathobiome and microbiome science are transforming the understanding of Lyme disease, infection, and neurodegeneration. Learn More Learn more about the Alzheimer's Pathobiome Initiative (AlzPI) Listen to Tick Boot Camp Podcast episodes, including Episode 406: Pathobiome – An Interview with Nikki Schultek and Episode 101: The Young Gun – An Interview with Alex (Ali) Moresco discussed in this interview.

Today, we'll talk with one of the true giants of stroke neurology - Dr. Louis Caplan, Professor of Neurology at Harvard Medical School and Senior Neurologist at Beth Israel Deaconess Medical Center. For decades, Dr. Caplan has shaped how we think about stroke. He's authored an enormous body of work -- landmark papers, books, and clinical descriptions that have changed how neurologists around the world recognize and classify strokes. But today, rather than revisiting the past, we'll ask how he sees the future - of stroke, clinical reasoning in an era of AI, and of medicine itself. Dr. Caplan was interviewed by Dr. Sarah Nelson, neurointensivist and Assistant Professor of Neurology at Tufts Medical Center. Series 7, Episode 2  Disclosures: None

Obesity is a chronic disease. So why are we still not treating it as such?Enter Dr. Fatima Cody Stanford, Associate Professor of Medicine and Pediatrics at Harvard Medical School and Massachusetts General Hospital.Dr. Stanford is a global voice on obesity - redefining it as a chronic disease, not a personal failure.In taking us through the science behind it, Dr. Stanford guides us to the heart of several patient stories, highlighting the need for treating patients with dignity, improving access to care, and eliminating biases in global healthcare.——We spoke about genetic, environmental, and systemic factors that contribute to obesity, the efficacy of treatments like GLP-1 receptor agonists, real-life examples, the emotional and practical aspects of this chronic disease, and the need to involve healthcare professionals, government, and the community to tackle the global obesity epidemic.Follow me on Instagram and Facebook @ericfethkemd and checkout my website at www.EricFethkeMD.com. My brand new book, The Privilege of Caring, is out now on Amazon! https://www.amazon.com/dp/B0CP6H6QN4

On 28 September 2024, a conversation between Dr. Vivek Murthy, MD, US Surgeon General, and Sadhguru where they will explore "Loneliness: In is the Only Way Out". Hosted at the Joseph B. Martin Conference Room, Harvard Medical School, Boston, the session will be moderated by Bala Subramaniam, MD, MPH, Director of Sadhguru Center for a Conscious Planet. Set the context for a joyful, exuberant day with a short, powerful message from Sadhguru. Explore a range of subjects with Sadhguru, discover how every aspect of life can be a stepping stone, and learn to make the most of the potential that a human being embodies.  Conscious Planet: ⁠https://www.consciousplanet.org⁠ Sadhguru App (Download): ⁠https://onelink.to/sadhguru__app⁠ Official Sadhguru Website: ⁠https://isha.sadhguru.org⁠ Sadhguru Exclusive: ⁠https://isha.sadhguru.org/in/en/sadhguru-exclusive⁠ Inner Engineering Link: isha.co/ieo-podcast Yogi, mystic and visionary, Sadhguru is a spiritual master with a difference. An arresting blend of profundity and pragmatism, his life and work serves as a reminder that yoga is a contemporary science, vitally relevant to our times. Learn more about your ad choices. Visit megaphone.fm/adchoices

This week we review the topic of mitral annular disjunction ("MAD") and the possible association with ventricular arrhythmia or sudden death in the connective tissue disease patient. Is there a 'cut off' distance above which patients deserve more significant arrhythmia surveillance? What is the best way to measure the MAD distance? Can patients with low MAD distances have lower degrees or even no arrhythmic surveillance? How often should this distance be measured on CMR and can an echo measurement provide similar data? Dr. Daniel Castellanos, the first author of this work and Assistant Professor of Pediatrics at Harvard Medical School shares his deep insights this week.DOI: 10.1016/j.jocmr.2025.101954

Pre-Order The Forever Strong PLAYBOOK and receive exclusive bonuses: https://drgabriellelyon.com/playbook/Want ad-free episodes, exclusives and access to community Q&As? Subscribe to Forever Strong Insider: https://foreverstrong.supercast.comIn this compilation episode, Dr. Gabrielle Lyon is joined by the top experts in Testosterone and men's health treatments. You'll learn:Why aging alone doesn't drop T levels and why acquisition of conditions like obesity is the real culprit.Why the standard "low T" cutoff is misleading and why you must check your Free Testosterone.How erectile dysfunction is a sensitive marker of overall health and heart risk.The efficacy of Cialis/Viagra for both erections and cardiac protection, and the risks of unchecked influencer advice on steroids.The direct link between muscle mass, exercise, and sexual function—and why the penis is the "first to go" when overall health declines.Chapter Markers:0:00 - Testosterone is a Brain Hormone0:40 - Debunking the Myth: Male Menopause (Andropause) Doesn't Exist1:33 - The Dangers of Unchecked Influencer Advice on Testosterone3:07 - Defining Testosterone Deficiency: Symptoms vs. Signs5:10 - The Arbitrary Number: Why Guidelines Disagree on Low T8:29 - Free Testosterone: The Most Reliable Indicator of Male Health15:28 - TRT vs. Steroids: Defining the Line and Risks18:59 - The Real Risks of TRT: Infertility and Hematocrit22:36 - The Shocking Backstory: Challenging the Prostate Cancer Myth26:40 - Erectile Dysfunction (ED) and Lifestyle Modification29:21 - Shockwave Therapy for ED: The Science and the Cash Business33:53 - Penile Tissue Atrophy and Venous Leak37:25 - The Role of Muscle Mass, Sarcopenia, and Sexual Function39:41 - The Single Best Marker for Male Health: Erectile Function42:02 - The Science of Cialis and Viagra (PDE5 Inhibitors)45:49 - The Viagra Story: From Heart Drug to ED Cure50:50 - Tadalafil (Cialis) as a Triple-Threat Drug (Cardiac, Urinary, Sexual)53:57 - The Role of Testosterone in Female Sexual Function55:20 - Hypogonadism: Diagnosis, Treatment, and Fertility RiskAbout the guests: Dr. Abraham Morgentaler is an Associate Clinical Professor of Urology at Harvard Medical School and founder of Men's Health Boston. He is an internationally recognized expert in men's health, particularly known for his pioneering work in testosterone therapy. Dr. Morgentaler is credited with reversing the long-held belief that testosterone therapy causes prostate cancer and is the author of several books on men's health. YouTubeLinkedInT4L EducationX/Twitter Dr. Tobias Kohler is the co-founder of the Erectile Restoration Outcomes Study (EROS) penile implant registry. In addition to his clinical and research activities, Dr. Kohler is active in education, providing mentorship to residents and fellows.Mayo Clinic ResearchGateLinkedIn

I sit down with Dr. David Rosmarin, an associate professor at Harvard Medical School and a pioneer bridging the worlds of spirituality and clinical psychology. We explore a powerful, yet often ignored, truth in mental health: that for many, emotional distress is a crisis of meaning and spirit. David shares the fascinating research from his work at McLean Hospital, and we tackle the tough questions—are we over-medicalizing normal human anxiety? Could connecting with our spiritual nature be a more effective path to healing? This is a crucial conversation about bringing the soul back into mental health care.00:00 Intro02:42 The Genesis of Spirituality05:12 How Do You Define Spirituality?10:32 The Chasm Between Patient Needs and Clinical Training12:08 Humanizing Care: From Medication to Meaning18:21 A Case Study: Crisis of Meaning20:37 The Four Steps to Face Anxiety28:41 Anxiety as an Existential Opportunity31:01 Spiritual Mentorship: Crisis and Healing Are One34:40 Are We Over-Pathologizing Normal Anxiety?37:17 The Benzodiazepine Crisis and Over-Medication41:21 How to Find Dr. Rosmarin's Work42:53 Conclusion Learn more about Dr. David Rosmarin:· dhrosmarin.com· spirit.mclean.harvard.eduIn The Space Between membership, you'll get access to LIVE quarterly Ask Amy Anything meetings (not offered anywhere else!), discounts on courses, special giveaways, and a place to connect with Amy and other like-minded people. You'll also get exclusive access to other behind-the-scenes goodness when you join! Click here to find out more --> https://shorturl.at/vVrwR - IG- https://tinyurl.com/ysvafdwc- FB - https://tinyurl.com/yc3z48v9- YT - https://tinyurl.com/ywdsc9vt- Web - https://tinyurl.com/ydj949kt Life, Death & the Space Between Dr. Amy RobbinsExploring life, death, consciousness and what it all means. Put your preconceived notions aside as we explore life, death, consciousness and what it all means on Life, Death & the Space Between.**Brought to you by:Dr. Amy Robbins | Host, Executive ProducerPodcastize.net | Audio & Video Production | Hosted on Acast. See acast.com/privacy for more information.

Start Your Transformation Now In this episode of the Transform Your Life podcast, I talk about the importance of living your own purpose in life rather than conforming to the expectations and ideals of others. I talk about how we can get stuck in careers, relationships, and situations that don't align with our true desires because we seek the approval of our parents, partners, and society. I ask you to explore whether you are truly living a purposeful, fulfilling life on your own terms or living your life for others. As I ask the last question, I think back to the 1991 movie, The Dead Poet's Society, and I think about the movie character named Neil. He wanted to pursue acting and loved it, but his stern father wanted him to go to Harvard Medical School. Neil hated the idea of medical school and found it soul-crushing, but he agreed. You'll have to watch the movie for the story's conclusion, but it's not uncommon for people to deny their own hopes, wishes, wants, and dreams and instead live their lives to please their parents. Often times cultural and familial pressures guide people down a path that doesn't fulfill them, and they live decades misaligned from their own purpose while trying to please others. So, it's important to ask whether you are living your own purpose or someone else's. Another purpose-robbing action that people often get into is seeking validation from others. This is a surefire way to live an unfulfilled life. For example, a friend of mine was constantly motivated by a desire for his father's approval, and that led him down an obsessive path of constantly trying to prove himself. This behavior disconnects you from your higher self and obscures your true purpose. You can't create an authentic life while dependent on external validation. I have found that the key to living your purpose is surrendering to your destiny and innate talents. This involves getting quiet, listening to your intuition, and taking aligned action. We must focus on the importance of being grateful and on contribution rather than achievement. Here are four key points you may want to keep in mind: Surrender to your innate talents and destiny.Listen to your intuition and take aligned action.Express gratitude and focus on contributing.Achievements will naturally follow purposeful contributions. You must examine whether you are living someone else's purpose or your own. If you are not thrilled by how you spend your days, you are likely conforming to others' expectations. I challenge you to get creative, listen within, and take steps each day to live your own purpose. Listen, apply, and enjoy! Transformational Takeaway When you are living your purpose, you are contributing your talents to activities that light you up, and you will experience true joy and fulfillment. Your key is being brave enough to live life on your own terms. Just do it. Mentioned Resources: EPISODE 280: History, Humanity, and Spiritual Ego. EPISODE 236: Living Life on Your Own Terms Let's Connect:Instagram | Facebook | YouTube | LinkedIn LIKED THE EPISODE?If you're the kind of person who likes to help others, then share this with your friends and family. If you have found value, they will too. Please leave a review on Apple Podcasts so we can reach more people. Listening on Spotify? Please leave a comment below. We would love to hear from you! With gratitude,Jim